Pheonix sales director Jeremy Meader is to become the new managing director of independent support group Numark.
Related Article: Nearly twice as many patients in deprived areas prescribed dependency-forming meds
Mr Meader will succeed John D’Arcy in the post from 1 February, the company announced today (8 November).
Related Article: Finding sustainable funding solution is ‘matter of urgency’ for government
Mr D’Arcy announced his intention to step down as managing director in July after a decade with the company, but intends stay on as Numark’s non-executive chairman for at least two years.
Numark said: ‘Jeremy brings with him huge experience and knowledge of not only the sector but a unique understanding of the Numark membership, having headed up the pharmacy development team, during which time membership growth reached an all-time high in both existing and new channels.’
Related Article: NICE recommends ‘game changer’ wearable tech for type 1 diabetes
Steve Anderson, group managing director Phoenix UK, said: ‘We have a great team at Numark and we are going from strength to strength with ambitious growth plans over the coming years. Our sector is facing many challenges, but I know Jeremy and John will develop the solutions and support our customers need to succeed.’
Have your say
Please add your comment in the box below. You can include links, but HTML is not permitted. Please note that comments are not moderated before publication and the views expressed are those of the user and do not reflect the views of The Pharmacist. Remember that submission of comments is governed by our Terms and Conditions. You can also read our full guidelines on article comments here – but please be aware that you are legally liable for any libellous or offensive comments that you make. If you have a complaint about a comment or are concerned that a comment breaches our terms and conditions, please use the ‘Report this comment’ function to alert our web team.